查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1231632

临床实验管理系统(CTMS)的全球市场

Clinical Trial Management Systems (CTMS)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 208 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

临床实验管理系统(CTMS)的全球市场到2030年将达到40亿美元

在COVID-19后改变的商务环境中，2022年14亿美元的临床实验管理系统(CTMS)的全球市场，在2022年～2030年预计将以年复合成长率14％增长，2030年达到40亿美元。本报告所分析之市场区隔之一的企业级CTMS将记录年复合成长率14.8％，到分析期间结束时达到28亿美元。考虑疫情后的復苏，现场CTMS领域今后8年的年复合成长率将修正为12.5％。

美国市场估算为4亿1,110万美元，中国预计以年复合成长率13.2％增长

美国的临床实验管理系统(CTMS)市场在2022年估算为4亿1,110万美元。作为世界第2大经济大国的中国，在2022年～2030年年复合成长率预计将为13.2％，2030年达到6亿8,490万美元的市场规模。其他热门的地区市场有日本和加拿大，在2022年～2030年预计将各以12.1％和11％的速度成长。在欧洲市场中，德国预计将以年复合成长率8.5％成长。

调查对像企业范例

  • ArisGlobal LLC
  • BioClinica Inc.
  • Bio-Optronics Inc.
  • DSG Inc.
  • eResearch Technology Inc.
  • IBM Watson Health
  • Medidata Solutions
  • MedNet Solutions
  • Nextrials Inc.
  • Oracle Corp.
  • PAREXEL International Corp.
  • Trial By Fire Solutions LLC
  • Veeva Systems Inc.

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 全球其他地区

第4章 竞争

简介目录
Product Code: MCP-6222

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Clinical Trial Management Systems (CTMS) Market to Reach $4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Clinical Trial Management Systems (CTMS) estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$4 Billion by 2030, growing at aCAGR of 14% over the period 2022-2030. Enterprise-Wide CTMS, one of the segments analyzed in the report, is projected to record 14.8% CAGR and reach US$2.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the On-Site CTMS segment is readjusted to a revised 12.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $411.1 Million, While China is Forecast to Grow at 13.2% CAGR

The Clinical Trial Management Systems (CTMS) market in the U.S. is estimated at US$411.1 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$684.9 Million by the year 2030 trailing a CAGR of 13.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 11% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.

Select Competitors (Total 71 Featured):

  • ArisGlobal LLC
  • BioClinica Inc.
  • Bio-Optronics Inc.
  • DSG Inc.
  • eResearch Technology Inc.
  • IBM Watson Health
  • Medidata Solutions
  • MedNet Solutions
  • Nextrials Inc.
  • Oracle Corp.
  • PAREXEL International Corp.
  • Trial By Fire Solutions LLC
  • Veeva Systems Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Clinical Trial Management Systems (CTMS) Gain Ground
    • Recent Market Activity
    • Benefits Offered by CTMS
    • Global Market Overview
    • Clinical Trial Management Systems Market to Post Explosive Growth
    • Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth
    • Key Players in the CTMS Market
    • Developed Countries Rule the Market
    • Pharmaceutical Firms and CROs to Drive Adoption Rate
    • Noteworthy Transformations in the Global Clinical Trial Sector
    • Clinical Trial Management Systems (CTMS) - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Clinical Trial Globalization Surges Demand for CTMS
  • 2. FOCUS ON SELECT PLAYERS
    • ArisGlobal, LLC (USA)
    • BioClinica, Inc. (USA)
    • Bio-Optronics, Inc. (USA)
    • DSG, Inc. (USA)
    • eResearch Technology, Inc. (USA)
    • IBM Watson Health (USA)
    • MedNet Solutions (USA)
    • Medidata Solutions (USA)
    • Nextrials, Inc. (USA)
    • Oracle Corp. (USA)
    • PAREXEL International Corp. (USA)
    • Trial By Fire Solutions, LLC (USA)
    • Veeva Systems, Inc. (USA)
    • Winchester Business Systems (USA)
  • 3. MARKET TRENDS & DRIVERS
    • Surging Global Population Offers Increased Growth Opportunities
    • Increased Spend on R&D - An Important Growth Driver
    • CROs - The Targeted Customers for CTMS
    • Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand
    • CROs Adept with New Technologies to See More Business in Future
    • Rise in Clinical Trial Complexities Propels CTMS Demand
    • Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand
    • Adoption of Digital Technologies Gains Pace
    • Clinical Trial Operators Demand Efficient Data Management Platforms
    • DLB System's Solution with Data Management Tools
    • Systems Integration Becomes Imperative
    • Technological Innovations Drive Market Growth
    • MC10 Introduces BioStampRC System to Capture Clinical Trial Data
    • UF Health Cancer Center Unveils OnCore® Clinical Trials Management System
    • UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Licensed Enterprise (On-Premise) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Enterprise-Wide CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Enterprise-Wide CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Enterprise-Wide CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for On-Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for On-Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for On-Site CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Web-Based (On-demand) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Web-Based (On-demand) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Web-Based (On-demand) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cloud (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cloud (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Cloud (SaaS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Large Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Large Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Large Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 34: World Clinical Trial Management Systems (CTMS) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • JAPAN
    • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • CHINA
    • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: China 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: China 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • EUROPE
    • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • FRANCE
    • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: France 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: France 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: France 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • GERMANY
    • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by Delivery mode - Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Delivery mode - Percentage Breakdown of Value Sales for Web-Based (On-demand), Licensed Enterprise (On-Premise) and Cloud (SaaS) for the Years 2014, 2023 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by End-Use - Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Clinical Trial Management Systems (CTMS) by End-Use - Percentage Breakdown of Value Sales for Large Pharma-Biotech Companies, CROs, Medical Device Manufacturers, Small & Mid-Sized Pharma-Biotech Companies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Clinical Trial Management Systems (CTMS) by Deployment - Enterprise-Wide CTMS and On-Site CTMS Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Deployment - Percentage Breakdown of Value Sales for Enterprise-Wide CTMS and On-Site CTMS for the Years 2014, 2023 & 2030

IV. COMPETITION